Top

Sleep and Breathing

Published in:

01-05-2016 | Sleep Breathing Physiology and Disorders • Original Article

Long-term efficacy of an oral appliance in early treated patients with obstructive sleep apnea

Author: Marie Marklund

Published in: Sleep and Breathing | Issue 2/2016

Abstract

Purpose

The purpose of the present study was to evaluate the long-term efficacy of oral appliances (OAs) in early treated patients with obstructive sleep apnea (OSA).

Method and patients

Polysomnographic sleep recordings without and with an OA were performed at treatment start and in patients who had been continuously treated with OAs for at least 15 years.

Results

Nine patients (eight men) with a median age of 68.1 years (interquartile range (IQR) 60.0 to 76.3 years) and a median treatment time of 16.5 years (IQR 16.3 to 18.0 years) were included. The apnea–hypopnea index decreased from a median of 17.3 (IQR 9.7 to 26.5) to 7.2 (IQR 4.0 to 9.6; p = 0.03) at the short-term follow-up. After long-term use, the apnea–hypopnea index was 32.4 (IQR 22.2 to 58.8) without the device and 35.1 (IQR 13.6 to 46.2) with it (p = 0.08). There were increases in the apnea–hypopnea index, both without the device (p = 0.02) and with it (p = 0.008). The degree of mandibular advancement did not differ between the two study occasions (p = 1.0).

Conclusions

Patients treated with oral appliances may experience deteriorations in disease severity and treatment efficacy during continuous long-term OA treatment. Regular follow-up schedules with renewed sleep apnea recordings should be considered for these patients in order to avoid suboptimal or a total loss of effects on sleep apneas.

Marklund M, Franklin KA (2015) Treatment of elderly patients with snoring and obstructive sleep apnea using a mandibular advancement device. Sleep Breath 19:403–405CrossRefPubMed

Dal-Fabbro C, Garbuio S, D'Almeida V, Cintra FD, Tufik S, Bittencourt L (2014) Mandibular advancement device and CPAP upon cardiovascular parameters in OSA. Sleep and Breathing 18:749–759CrossRefPubMed

Marklund M, Verbraecken J, Randerath W (2012) Non-CPAP therapies in obstructive sleep apnoea: mandibular advancement device therapy. Eur Respir J 39:1241–1247CrossRefPubMed

Sutherland K, Vanderveken OM, Tsuda H, Marklund M, Gagnadoux F, Kushida CA, Cistulli PA (2014) Oral appliance treatment for obstructive sleep apnea: an update. J Clin Sleep Med 10:215–227PubMedPubMedCentral

Marklund M, Carlberg B, Forsgren L, Olsson T, Stenlund H, Franklin KA (2015) Oral appliance therapy in patients with daytime sleepiness and snoring or mild to moderate sleep apnea: a randomized clinical trial. JAMA Internal Med 175:1278–1285CrossRef

Hoekema A, Stegenga B, Wijkstra PJ, van der Hoeven JH, Meinesz AF, de Bont LG (2008) Obstructive sleep apnea therapy. J Dent Res 87:882–887CrossRefPubMed

Holley AB, Lettieri CJ, Shah AA (2011) Efficacy of an adjustable oral appliance and comparison with continuous positive airway pressure for the treatment of obstructive sleep apnea syndrome. Chest 140:1511–1516CrossRefPubMed

Vanderveken OM, Dieltjens M, Wouters K, De Backer WA, Van de Heyning PH, Braem MJ (2013) Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing. Thorax 68:91–96CrossRefPubMedPubMedCentral

Phillips CL, Grunstein RR, Darendeliler MA, Mihailidou AS, Srinivasan VK, Yee BJ, Marks GB, Cistulli PA (2013) Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 187:879–887CrossRefPubMed

10.

Aarab G, Lobbezoo F, Heymans MW, Hamburger HL, Naeije M (2011) Long-term follow-up of a randomized controlled trial of oral appliance therapy in obstructive sleep apnea. Respiration 82:162–168CrossRefPubMed

11.

Gauthier L, Laberge L, Beaudry M, Laforte M, Rompre PH, Lavigne GJ (2011) Mandibular advancement appliances remain effective in lowering respiratory disturbance index for 2.5-4.5 years. Sleep Med 12:844–849CrossRefPubMed

12.

Ghazal A, Sorichter S, Jonas I, Rose EC (2009) A randomized prospective long-term study of two oral appliances for sleep apnoea treatment. J Sleep Res 18:321–328CrossRefPubMed

13.

Marklund M, Sahlin C, Stenlund H, Persson M, Franklin KA (2001) Mandibular advancement device in patients with obstructive sleep apnea: long-term effects on apnea and sleep. Chest 120:162–169CrossRefPubMed

14.

Rose EC, Barthlen GM, Staats R, Jonas IE (2002) Therapeutic efficacy of an oral appliance in the treatment of obstructive sleep apnea: a 2-year follow-up. Am J Orthod Dentofacial Orthop 121:273–279CrossRefPubMed

15.

Walker-Engstrom ML, Tegelberg A, Wilhelmsson B, Ringqvist I (2002) 4-year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest 121:739–746CrossRefPubMed

16.

Doff MH, Hoekema A, Wijkstra PJ, van der Hoeven JH, Huddleston Slater JJ, de Bont LG, Stegenga B (2013) Oral appliance versus continuous positive airway pressure in obstructive sleep apnea syndrome: a 2-year follow-up. Sleep 36:1289–1296PubMedPubMedCentral

17.

Fransson AM, Tegelberg A, Leissner L, Wenneberg B, Isacsson G (2003) Effects of a mandibular protruding device on the sleep of patients with obstructive sleep apnea and snoring problems: a 2-year follow-up. Sleep Breath 7:131–141CrossRefPubMed

18.

Wiman Eriksson E, Leissner L, Isacsson G, Fransson A (2014) A prospective 10-year follow-up polygraphic study of patients treated with a mandibular protruding device. Sleep Breath 19:393–401CrossRefPubMed

19.

Marklund M, Stenlund H, Franklin KA (2004) Mandibular advancement devices in 630 men and women with obstructive sleep apnea and snoring: tolerability and predictors of treatment success. Chest 125:1270–1278CrossRefPubMed

20.

Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force (1999). Sleep 22:667–689

21.

Rechtschaffen AKA (1968) (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Barin Information Service/Brain Research Institute, Los Angeles

22.

Vroegop AV, Smithuis JW, Benoist LB, Vanderveken OM, de Vries N (2015) CPAP washout prior to reevaluation polysomnography: a sleep surgeon's perspective. Sleep Breath 19:433–439CrossRefPubMed

23.

Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177:1006–1014CrossRefPubMedPubMedCentral

24.

Sutherland K, Cistulli PA (2015) Recent advances in obstructive sleep apnea pathophysiology and treatment. Sleep Biol Rhythms 13:26–40CrossRef

25.

Cistulli PA, Gotsopoulos H, Marklund M, Lowe AA (2004) Treatment of snoring and obstructive sleep apnea with mandibular repositioning appliances. Sleep Med Rev 8:443–457CrossRefPubMed

26.

Netzer NC, Juhasz J, Hofmann M, Hohl K, Strohl KP, Kupper TE (2011) The need for pressure changes in CPAP therapy 2–3 months after initial treatment: a prospective trial in 905 patients with sleep-disordered breathing. Sleep Breath 15:107–112CrossRefPubMed

27.

Rossi VA, Schwarz EI, Bloch KE, Stradling JR, Kohler M (2014) Is continuous positive airway pressure necessarily an everyday therapy in patients with obstructive sleep apnoea? Eur Respir J 43:1387–1393CrossRefPubMed

28.

Filtness AJ, Reyner LA, Horne JA (2012) One night's CPAP withdrawal in otherwise compliant OSA patients: marked driving impairment but good awareness of increased sleepiness. Sleep Breath 16:865–871CrossRefPubMed

29.

Young LR, Taxin ZH, Norman RG, Walsleben JA, Rapoport DM, Ayappa I (2013) Response to CPAP withdrawal in patients with mild versus severe obstructive sleep apnea/hypopnea syndrome. Sleep 36:405–412PubMedPubMedCentral

Title: Long-term efficacy of an oral appliance in early treated patients with obstructive sleep apnea
Author: Marie Marklund
Publication date: 01-05-2016
Publisher: Springer Berlin Heidelberg
Published in: Sleep and Breathing / Issue 2/2016
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-015-1280-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Method and patients

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2016

Does experimental paradoxical sleep deprivation (EPSD) is an appropriate model for evaluation of cardiovascular complications of obstructive sleep apnea?

Poor sleep quality associated with obesity in men

High-resolution wrist-worn overnight oximetry has high positive predictive value for obstructive sleep apnea in a sleep study referral population

Diagnostic validity of the use of a portable single-channel electromyography device for sleep bruxism

Association between sleep quality and inflammatory complement components in collegiate males

The Determining Risk of Vascular Events by Apnea Monitoring (DREAM) study: design, rationale, and methods

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials